Rapport

• Botton, J., Rios, P., Drouin, J., Miranda, S., Zureik, M., Weill, A., & Dray-Spira, R. (2025). Exposition paternelle au valproate au cours de la spermatogenèse et risque de troubles neurodéveloppementaux chez l’enfant—Étude nationale à partir du registre EPI-MERES. [lien]

Articles publiés dans des revues à Comité de lecture

• Peyre, H., Rios, P., Botton, J., Herlemont, P., Olié, V., Miranda, S., Zureik, M., Weill, A., & Dray-Spira, R. (2026). Shared and disorder-specific prenatal and perinatal risk factors for neurodevelopmental disorders : A nationwide cohort study. Molecular Psychiatry, 1‑10. [lien]
• Blotière, P.-O., Miranda, S., Weill, A., Mikaeloff, Y., Peyre, H., Ramus, F., Mahmoud, Z., Coste, J., & Dray-Spira, R. (2020). Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy : A French nationwide population-based cohort study. BMJ Open, 10(6), e034829. [link]
• Coste, J., Blotiere, P.-O., Miranda, S., Mikaeloff, Y., Peyre, H., Ramus, F., Zureik, M., Weill, A., & Dray-Spira, R. (2020). Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs : A nationwide cohort study in France. Scientific Reports, 10(1), Article 1. [link]